Agilon Health (AGL)
(Delayed Data from NYSE)
$6.75 USD
-0.01 (-0.15%)
Updated Jul 25, 2024 04:00 PM ET
4-Sell of 5 4
D Value D Growth A Momentum C VGM
Cash flow Statements
Fiscal Year End for Agilon Health, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -262.80 | -106.86 | -406.79 | -60.05 | -282.74 |
Depreciation/Amortization & Depletion | 20.16 | 13.77 | 14.67 | 14.10 | 41.41 |
Net Change from Assets/Liabilities | -10.07 | -59.44 | -55.03 | 6.47 | 33.18 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 96.51 | 21.72 | 298.98 | -13.72 | 104.29 |
Net Cash From Operating Activities | -156.20 | -130.81 | -148.16 | -53.20 | -103.86 |
Property & Equipment | -15.83 | -15.43 | -6.56 | -1.78 | -2.89 |
Acquisition/ Disposition of Subsidiaries | 2.19 | 0.50 | -1.34 | 26.21 | 0.00 |
Investments | 29.86 | -412.23 | -75.74 | -1.79 | -1.15 |
Other Investing Activities | -60.24 | -17.24 | -6.86 | -0.58 | -1.01 |
Net Cash from Investing Activities | -44.02 | -444.39 | -90.51 | 22.07 | -5.06 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -188.13 | 33.06 | 1,189.03 | 27.66 | 180.19 |
Issuance (Repayment) of Debt | -5.00 | -5.00 | -19.90 | -3.04 | -3.59 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | -0.30 |
Other Financing Activities | 0.00 | 0.00 | -14.74 | 0.00 | 0.00 |
Net Cash from Financing Activities | -193.13 | 28.06 | 1,154.39 | 24.62 | 176.30 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -393.35 | -547.14 | 915.73 | -6.52 | 67.38 |
Cash at Beginning of Period | 507.68 | 1,054.82 | 139.10 | 145.61 | 78.24 |
Cash at End of Period | 114.33 | 507.68 | 1,054.82 | 139.10 | 145.61 |
Diluted Net EPS | -0.64 | -0.26 | -1.09 | -0.19 | NA |
Fiscal Year End for Agilon Health, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -6.03 | -262.80 | -32.32 | -0.84 |
Depreciation/Amortization & Depletion | NA | 5.84 | 20.16 | 15.01 | 9.70 |
Net Change from Assets/Liabilities | NA | -63.34 | -10.07 | -105.69 | -111.96 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 15.75 | 96.51 | 27.96 | 21.07 |
Net Cash From Operating Activities | NA | -47.78 | -156.20 | -95.03 | -82.02 |
Property & Equipment | NA | -3.14 | -15.83 | -11.90 | -7.81 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 2.19 | 0.00 | 0.00 |
Investments | NA | 66.02 | 29.86 | 18.10 | 23.23 |
Other Investing Activities | NA | -11.44 | -60.24 | -48.01 | -46.20 |
Net Cash from Investing Activities | NA | 51.44 | -44.02 | -41.82 | -30.78 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 1.81 | -188.13 | -188.54 | -191.20 |
Issuance (Repayment) of Debt | NA | -1.25 | -5.00 | -3.75 | -2.50 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | 0.56 | -193.13 | -192.29 | -193.70 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | 4.22 | -393.35 | -329.14 | -306.50 |
Cash at Beginning of Period | NA | 114.33 | 507.68 | 507.68 | 507.68 |
Cash at End of Period | NA | 118.55 | 114.33 | 178.54 | 201.19 |
Diluted Net EPS | NA | -0.02 | -0.56 | -0.08 | -0.04 |